Browsing by Author "Atay, Hilmi"
Now showing items 1-5 of 5
-
The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia
Aksu, Salih; Sahin, Fahri; Uz, Burak; Yavuz, Selim A.; Atay, Hilmi; Kelkitli, Engin; Haznedaroglu, Ibrahim C. (Akad Doktorlar Yayinevi, 2012)We report our experience in 41 patients with chronic phase (CF)-chronic myeloid leukemia (CML) who had discontinued imatinib switched to dasatinib, retrospectively. The CF-CML patients received dasatinib at starting dose ... -
EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz, Burak; Buyukasik, Yahya; Atay, Hilmi; Kelkitli, Engin; Turgut, Mehmet; Bektas, Ozlen; Haznedaroglu, Ibrahim C. (Taylor & Francis Ltd, 2013)Objectives: The validity of the three currently used chronic myeloid leukemia (CML) scoring systems (Sokal CML prognostic scoring system, Euro/Hasford CML scoring system, and the EUTOS CML prognostic scoring system) were ... -
Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan, Umit Y.; Aksu, Salih; Aktimur, Sude H.; Atay, Hilmi; Bektas, Ozlen; Buyukasik, Yahya; Haznedaroglu, Ibrahim C. (Akad Doktorlar Yayinevi, 2015)Unsustainable drug prices in chronic myeloid leukemia (CML) and cancer may be causing harm to patients. The aim of this multi-center study is to assess the efficacy of generic imatinib mesylate (IM) over Glivec in terms ... -
Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio
Kelkitli, Engin; Atay, Hilmi; Cilingir, Fatih; Guler, Nil; Terzi, Yuksel; Ozatli, Duzgun; Turgut, Mehmet (Springer, 2014)The neutrophil/lymphocyte ratio (NLR) at diagnosis has been shown to be a prognostic factor for survival in solid tumors. The NLR at diagnosis as a prognostic factor for multiple myeloma (MM) has not been studied. Therefore, ... -
The Relationship of T Helper-2 Pathway Components Interleukin-4, Interleukin-10, Immunoglobulin E, and Eosinophils with Prognostic Markers in Non-Hodgkin Lymphoma: A Case-Control Study
Guler, Nil; Kelkitli, Engin; Atay, Hilmi; Erdem, Dilek; Alacam, Hasan; Bek, Yuksel; Yucel, Idris (Galenos Yayincilik, 2014)Objective: Increased risk for non-Hodgkin lymphoma (NHL) is associated with infections and environmental agents. We hypothesized that these factors chronically trigger the T helper-2 (Th2) pathway and result in lymphoma. ...
